Human Papillomavirus Type 11 L1 Protein Adsorbed
Generic Name: human papillomavirus type 11 l1 protein adsorbed
Dosage form: LIQUID. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (.32 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: LIQUID. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (.32 mg/mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as liquid.
Related Medications
Mefloquine Hydrochloride
mefloquine hydrochloride
DESCRIPTION Mefloquine hydrochloride tablets, USP are an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228 mg of the free base) for oral administration. Mefloquine hydrochloride, USP is a 4-quinolinemethanol derivative with the specific chemical name of (R*, S*)-(±)-α-2-piperidinyl-2,8-bis (trifluoromethyl)-4-quinolinemethanol hydrochloride. It is a 2-aryl substituted chemical structural analog of quinine.
Glimepiride
glimepiride
Sulfonylurea [EPC]
11 DESCRIPTION Glimepiride tablets, USP are an oral sulfonylurea that contains the active ingredient glimepiride. Chemically, glimepiride is identified as 1-[[p-[2-(3-ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea (C 24 H 34 N 4 O 5 S) with a molecular weight of 490.62. Glimepiride USP is a white or almost white powder and is practically insoluble in water.
Ioxaglate Meglumine
ioxaglate meglumine
Manufactured by GUERBET. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IOXAGLATE MEGLUMINE (39.3%); IOXAGLATE SODIUM (19.6%). Application: NDA018905.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.